REVERE Trademark

Trademark Overview


On Tuesday, March 28, 2023, a trademark application was filed for REVERE with the United States Patent and Trademark Office. The USPTO has given the REVERE trademark a serial number of 97861964. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 14, 2025. This trademark is owned by Revere Pharmaceuticals, Inc.. The REVERE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment oncological diseases and conditions, kidney diseases and conditions, inflammatory diseases and conditions and central nervous system diseases and conditions
revere

General Information


Serial Number97861964
Word MarkREVERE
Filing DateTuesday, March 28, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, January 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment oncological diseases and conditions, kidney diseases and conditions, inflammatory diseases and conditions and central nervous system diseases and conditions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 20, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRevere Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressArlington, MA 02474

Party NameRevere Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressArlington, MA 02474

Trademark Events


Event DateEvent Description
Friday, March 31, 2023NEW APPLICATION ENTERED
Thursday, April 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 21, 2023ASSIGNED TO EXAMINER
Saturday, December 23, 2023NON-FINAL ACTION WRITTEN
Saturday, December 23, 2023NON-FINAL ACTION E-MAILED
Saturday, December 23, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 13, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 13, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 13, 2024SUSPENSION LETTER WRITTEN
Wednesday, March 13, 2024CORRESPONDENCE E-MAILED
Thursday, December 19, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 8, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 14, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 14, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED